header
Image from OpenLibrary

Plasma-soluble urokinase plasminogen activator receptor (suPAR) levels in behçet{u2019}s disease and correlation with disease activity / Arwa Osama Amin Alshaarawy ; Supervised Amal Hassan Rizk , Nora Yousry Elsaid , Walaa Abdelfattah Attia

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Arwa Osama Amin Alshaarawy , 2018Description: 161 P. : charts , facsimiles; 25cmOther title:
  • معدلات مستقبلات المنشط يوروكينيز بلازمينوجين القابلة للذوبان في البلازمة في مرض بهجت وعلاقته بنشاط المرض [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University -Faculty of Medicine - Department of Rheumatology and Rehabilitation Summary: Background: Behçet's disease (BD) is a chronic multisystemic vasculitic disease with unknown pathogenesis. Soluble urokinase plasminogen activator receptor (suPAR), a potential new biomarker, is a soluble form of membrane-bound receptors secreted from different immune cells.The Aim of the present study is to investigate plasma suPAR levels in Behçet's disease and their correlation with disease activity.Patients and Methods: Fifty Adult Behçet's disease patients determined according to the BD International Study Group criteria for Behçet's disease diagnosis and Fourty Adult healthy subjects were included in the present study. Enzyme-linked immunosorbent assay was employed to obtain quantitative data. Data of both groups were statistically analyzed.Results: The suPAR level was not statistically different between the Behçet{u2019}s disease patients and controls. For Behçet{u2019}s patients mean was of 0.2±0.5ng/mL compared to a mean of 0.3±0.4ng/mL for controls. P value was 0.413.This cross-sectional study showed that suPAR does not have any significant relation with disease activity in BD patients
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.32.M.Sc.2018.Ar.P (Browse shelf(Opens below)) Not for loan 01010110077323000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.32.M.Sc.2018.Ar.P (Browse shelf(Opens below)) 77323.CD Not for loan 01020110077323000

Thesis (M.Sc.) - Cairo University -Faculty of Medicine - Department of Rheumatology and Rehabilitation

Background: Behçet's disease (BD) is a chronic multisystemic vasculitic disease with unknown pathogenesis. Soluble urokinase plasminogen activator receptor (suPAR), a potential new biomarker, is a soluble form of membrane-bound receptors secreted from different immune cells.The Aim of the present study is to investigate plasma suPAR levels in Behçet's disease and their correlation with disease activity.Patients and Methods: Fifty Adult Behçet's disease patients determined according to the BD International Study Group criteria for Behçet's disease diagnosis and Fourty Adult healthy subjects were included in the present study. Enzyme-linked immunosorbent assay was employed to obtain quantitative data. Data of both groups were statistically analyzed.Results: The suPAR level was not statistically different between the Behçet{u2019}s disease patients and controls. For Behçet{u2019}s patients mean was of 0.2±0.5ng/mL compared to a mean of 0.3±0.4ng/mL for controls. P value was 0.413.This cross-sectional study showed that suPAR does not have any significant relation with disease activity in BD patients

Issued also as CD

There are no comments on this title.

to post a comment.